Encircling band, laser retinopexy and lens removal as standard procedure in complicated retinal detachment shows a good clinical outcome

Acta Ophthalmologica

Volumn 89, Issue 7, 2011, Pages 629-633

  Velikay Parel, Michaela ^a   Kiss, Christopher G ^b   Ivastinovic, Domagoj ^a   Richter Mueksch, Sibylla ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

encircling band; laser retinopexy; lensectomy; proliferative vitreoretinopathy; retinectomy; retinotomy; rhegmatogenous retinal detachment; silicone oil; vitrectomy

Indexed keywords

FLUOROCARBON; SILICONE OIL;

ADULT; AGED; ARTICLE; CERCLAGE; CHILD; DISEASE ASSOCIATION; EMMETROPIA; ENDOTAMPONADE; EPIRETINAL MEMBRANE; FEMALE; FOLLOW UP; HUMAN; LENSECTOMY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REOPERATION; RETINA DETACHMENT; RETINOPEXY; SCHOOL CHILD; SCLERA BUCKLING PROCEDURE; SURGICAL APPROACH; VISUAL ACUITY; VITREORETINAL SURGERY; VITREORETINOPATHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; ENDOTAMPONADE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASER THERAPY; LENS, CRYSTALLINE; MALE; MIDDLE AGED; RETINAL DETACHMENT; RETROSPECTIVE STUDIES; SCLERAL BUCKLING; SILICONE OILS; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE;

EID: 80155165318     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01763.x     Document Type: Article

References (23)

1. Abrams GW, Azen SP, McCuen BW II, Flynn HW Jr, Lai MY, &, Ryan SJ, (1997): Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11. Arch Ophthalmol 115: 335-344.
2. Charteris DG, Sethi CS, Lewis GP, &, Fisher SK, (2002): Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology. Eye 16: 369-374. (Pubitemid 34845964)
3. Charteris DG, Aylward GW, Wong D, Groenewald C, Asaria RH, &, Bunce C, (2004): A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy. Ophthalmology 111: 2240-2245. (Pubitemid 39575594)
4. Coll GE, Chang S, Sun J, Wieland MR, &, Berrocal MH, (1995): Perfluorocarbon Liquid in the management of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 102: 630-638.
5. Falkner CI, Binder S, &, Kruger A, (2001): Outcome after silicone oil removal. Br J Ophthalmol 85: 1324-1327. (Pubitemid 33016113)
6. Holladay JT, &, Prager TC, (1991): Mean visual acuity. Am J Ophthalmol 111: 372-374.
7. Hutton WL, Azen SP, Blumenkranz MS, et al., (1994): The effects of silicone oil removal. Silicone Study Report 6. Arch Ophthalmol 112: 778-785. (Pubitemid 24180513)
8. Jonas JB, Budde WM, &, Knorr HL, (1999): Timing of retinal redetachment after removal of intraocular silicone oil tamponade. Am J Ophthalmol 128: 628-631. (Pubitemid 29528602)
9. Jonas JB, Knorr HL, Rank RM, &, Budde WM, (2001): Retinal redetachment after removal of intraocular silicone oil tamponade. Br J Ophthalmol 85: 1203-1207. (Pubitemid 32929545)
10. La-Heij EC, Hendrikse F, &, Kessels AG, (2001): Results and complications of temporary silicone oil tamponade in patients with complicated retinal detachments. Retina 21: 107-114. (Pubitemid 32298767)
11. Laidlaw DA, Karia N, Bunce C, Aylward GW, &, Gregor ZJ, (2002): Is prophylactic 360 degree laser retinopexy protective? Risk factors for retinal redetachment after removal of silicone oil. Ophthalmology 109: 153-158. (Pubitemid 34027440)
12. Lam RF, Cheung BT, Yuen CY, Wong D, Lam DS, &, Lai WW, (2008): Retinal redetachment after silicone oil removal in proliferative vitreoretinopathy: a prognostic factor analysis. Am J Ophthalmol 145: 527-533.
13. Lesnoni G, Rossi T, Nistri A, &, Boccassini B, (2000): Long-term prognosis after removal of silicone oil. Eur J Ophthalmol 10: 60-65. (Pubitemid 30191106)
14. Lewis H, Aaberg TM, &, Abrams GW, (1991): Causes of failure after initial vitreoretinal surgery for severe proliferative vitreoretinopathy. Am J Ophthalmol 111: 8-14.
15. Quiram PA, Gonzales CR, Hu W, Gupta A, Yoshizumi MO, Kreiger AE, &, Schwartz SD, (2006): Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy. Ophthalmology 113: 2041-2047. (Pubitemid 44635708)
16. Schiff WM, Hwang JC, Ober MD, Olson JL, Dhrami-Gavazi E, Barile GR, Chang S, &, Mandava N, (2007): Safety and efficacy assessment of chimeric ribozyme to proliferating cell nuclear antigen to prevent recurrence of proliferative vitreoretinopathy. Arch Ophthalmol 125: 1161-1167. (Pubitemid 47403020)
17. Scholda C, Egger S, Lakits A, Walch K, von Eckardstein E, &, Biowski R, (2000): Retinal detachment after silicone oil removal. Acta Ophthalmol Scand 78: 182-186. (Pubitemid 30201427)
18. Scott IU, Flynn HW, Lai M, Chang S, &, Azen SP, (2000): First operation anatomic success and other predictors of postoperative vision after complex retinal detachment repair with vitrectomy and silicone oil tamponade. Am J Ophthalmol 130: 746-750.
19. Silicone Study Group (1992a): Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1. Arch Ophthalmol 110: 770-779.
20. Silicone Study Group (1992b): Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 2. Arch Ophthalmol 110: 780-792.
21. Steinberg EP, Tielsch JM, Schein OD, et al., (1994): The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol 112: 630-638. (Pubitemid 24155436)
22. Tseng JJ, Barile GR, Schiff WM, Akar Y, Vidne-Hay O, &, Chang S, (2005): Influence of relaxing retinotomy on surgical outcomes in proliferative vitreoretinopathy. Am J Ophthalmol 140: 628-636.
23. Wiedemann P, Hilgers RD, Bauer P, &, Heimann K, (1998): Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol 126: 550-559. (Pubitemid 28475919)